Abstract
Type 1 diabetes mellitus (T1D) is characterized by an elevation of blood glucose (hyperglycemia), a decrease in circulating levels of insulin, and the development of macro- and microvascular abnormalities. Hyperglycemia appears to be the primary determinant of the structural, functional, and biochemical abnormalities observed in large and small blood vessels of various organ systems during T1D. Hyperglycemia activates various cellular pathways/networks that undoubtedly produce/contribute to endothelial/vascular dysfunction via an increase in oxidative stress. Given that the structural, functional, and biochemical integrity of the brain depend upon the critical coupling between neural activity and cerebral blood flow (neurovascular coupling), alterations in this coupling by T1D could contribute to dysfunction of the blood–brain barrier and/or responses of large and small cerebral blood vessels in response to various stimuli. These abnormalities could then contribute to the pathogenesis of cognitive dysfunction and/or ischemic stroke observed in patients suffering with T1D. The purpose of this chapter is to discuss the role of oxidative stress in impaired cerebrovascular function during T1D. We will discuss critical pathways that produce oxidants and the potential role of these oxidants in the pathogenesis of cerebrovascular dysfunction and perhaps ischemic stroke during T1D. We suggest that a greater understanding regarding the nature of oxidants and antioxidants, and their sources, could lead to new and targeted therapeutic approaches for the treatment of cognitive dysfunction and stroke observed in diabetic subjects.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alexander JS, Elrod JW (2002) Extracellular matrix, junctional integrity and matrix metalloproteinase interactions in endothelial permeability regulation. J Anat 200:561–574
Alp NJ, Channon KM (2004) Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease. Arterioscler Thromb Vasc Biol 24:413–420
Alp NJ, Mussa S, Khoo J, Cai S, Guzik T, Jefferson A, Goh N, Rockett KA, Channon KM (2003) Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I overexpression. J Clin Invest 112:725–735
Arrick DM, Mayhan WG (2010) Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic rats. Microcirculation 17:439–446
Arrick DM, Sharpe GM, Sun H, Mayhan WG (2007) Diabetes-induced cerebrovascular dysfunction: role of poly(ADP-ribose) polymerase. Microvasc Res 73:1–6
Arrick DM, Sharpe GM, Sun H, Mayhan WG (2008) Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats. Brain Res 1209:128–135
Arrick DM, Sun H, Patel KP, Mayhan WG (2011) Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats. Am J Physiol Heart Circ Physiol 301:H696–H703
Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67:1890–1898
Awazu M, Parker RE, Harvie BR, Ichikawa I, Kon V (1991) Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17:S500–S502
Ayer RE, Zhang JH (2008) Oxidative stress in subarachnoid haemorrhage: significance in acute brain injury and vasospasm. Acta Neurochir Suppl 104:33–41
Bagi Z, Koller A (2003) Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type 1 diabetes is restored by sepiapterin. J Vasc Res 40:47–57
Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 271:C1424–C1437
Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313
Besson VC, Zsengeller Z, Plotkine M, Szabo C, Marchand-Verrecchia C (2005) Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res 1041:149–156
Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F (2005) Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Eur J Pharmacol 511:53–64
Bouloumie A, Bauersachs J, Linz W, Scholkens BA, Wiemer G, Fleming I, Busse R (1997) Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension 30:934–941
Brandes RP, Kreuzer J (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65:16–27
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813–820
Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615–1625
Brunmair B, Staniek K, Gras F, Scharf N, Althaym A, Clara R, Roden M, Gnaiger E, Nohl H, Waldhausl W, Furnsinn C (2004) Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53:1052–1059
Burkey JL, Campanale KM, O’Bannon DD, Cramer JW, Farid NA (2002) Disposition of LY333531, a selective protein kinase C beta inhibitor, in the Fischer 344 rat and beagle dog. Xenobiotica 32:1045–1052
Cappelli-Bigazzi M, Battaglia C, Pannain S, Chiariello M, Ambrosio G (1997) Role of oxidative metabolism on endothelium-dependent vascular relaxation of isolated vessels. J Mol Cell Cardiol 29:871–879
Channon KM (2004) Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 14:323–327
Cheetham C, Collis J, O’Driscoll G, Stanton K, Taylor R, Green D (2000) Losartan, an angiotensin type 1 receptor antagonist, improves endothelial function in non-insulin-dependent diabetes. J Am Coll Cardiol 36:1461–1466
Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003) Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 278:36027–36031
Chiarugi A (2005) Poly(ADP-ribosyl)ation and stroke. Pharmacol Res 52:15–24
Chiarugi A (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci 23:122–129
Chiu J, Xu BY, Chen S, Feng B, Chakrabarti S (2008) Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications. Can J Physiol Pharmacol 86:365–372
Chrissobolis S, Miller AA, Drummond GR, Kemp-Harper BK, Sobey CG (2011) Oxidative stress and endothelial dysfunction in cerebrovascular disease. Front Biosci 16:1733–1745
Chrissobolis S, Faraci FM (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Cell 14:495–502
Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Luscher TF (2003) High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107:1017–1023
Cosentino F, Hishikawa K, Katusic ZS, Luscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide generation in human aortic endothelial cells. Circulation 96:25–28
Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, Lentz SR (2004) Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35:1957–1962
Dhar A, Dhar I, Desai KM, Wu L (2010) Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose. Br J Pharmacol 16:1843–1856
Didion SP, Faraci FM (2003) Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke 34:2038–2042
Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM (2002) Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol 283:H1569–H1576
Didion SP, Hathaway CA, Faraci FM (2001) Superoxide levels and function of cerebral blood vessels after inhibition of CuZn-SOD. Am J Physiol 281:H1697–H1703
Didion SP, Sigmund CD, Faraci FM (2000) Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 31:760–765
Dincer Y, Akcay T, Alademir Z, Ilkova H (2002) Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 51:1360–1362
Dong L, Xie MJ, Zhang P, Ji LL, Liu WC, Dong MQ, Gao F (2009) Rotenone partially reverses decreased BK Ca currents in cerebral artery smooth muscle cells from streptozotocin-induced diabetic mice. Clin Exp Pharmacol Physiol 36:e57–e64
Du X, Matsumura T, Edelstein D, Rossetti L, Zsengeller Z, Szabo C, Brownlee M (2003) Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J Clin Invest 112:1049–1057
Duntas L, Keck FS, Haug C, Hetzel W, Wolf CF, Rosenthal J, Pfeiffer EF (1992) Serum angiotensin-converting enzyme activity and active renin plasma concentrations in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 16:203–208
Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089–1095
Fang Q, Sun H, Mayhan WG (2003) Impairment of nitric oxide synthase-dependent dilatation of cerebral arterioles during infusion of nicotine. Am J Physiol Heart Circ Physiol 284:H528–H534
Faraci FM (2011) Protecting against vascular disease in brain. Am J Physiol Heart Circ Physiol 300:H1566–H1582
Fatehi-Hassanabad Z, Imen-Shahidi M, Fatehi M, Farrokhfall K, Parsaeei H (2006) The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats. Eur J Pharmacol 535:228–233
Ferro T, Neumann P, Gertzberg N, Clements R, Johnson A (2000) Protein kinase C-a mediates endothelial barrier dysfunction induced by TNF-a. Am J Physiol 278:L1107–L1117
Fleegal-DeMotta MA, Doghu S, Banks WA (2009) Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells. J Cereb Blood Flow Metab 29:640–647
Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113:1708–1714
Frey RS, Rahman A, Kefer JC, Minshall RD, Malik AB (2002) PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 90:1012–1019
Fukai T, Galis ZS, Meng XP, Parthasarathy S, Harrison DG (1998) Vascular expression of extracellular superoxide dismutase in atherosclerosis. J Clin Invest 101:2101–2111
Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG (2000) Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 105:1631–1639
Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG (1999) Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 85:23–28
Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK (1997) p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80:45–51
Ganz MB, Seftel A (2000) Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am J Physiol 278:E146–E152
Gao X, Belmadani S, Picchi A, Xu X, Potter BJ, Tewar-Singh N, Capobianco S, Chilian WM, Zhang C (2007) Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. Circulation 115:245–254
Garcia Soriano F, Virag L, Jagtap P, Szabo E, Mabley JG, Liaudet L, Marton A, Hoyt DG, Murthy KG, Salzman AL, Southan GJ, Szabo C (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med 7(1):108–113
Garcia Soriano F, Pacher P, Mabley J, Liaudet L, Szabo C (2001) Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase. Circ Res 89:684–691
Garcia Soriano F, Virag L, Szabo C (2001) Diabetic endothelial dysfunction: role of reactive oxygen and nitrogen species production and poly(ADP-ribose) polymerase activation. J Mol Med 79:437–448
Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319–1331
Gerzanich V, Ivanova S, Zhou H, Simard JM (2003) Mislocalization of eNOS and upregulation of cerebral vascular Ca2+ channel activity in angiotensin-hypertension. Hypertension 41:1124–1130
Girouard H, Park L, Anrather J, Zhou P, Iadecola C (2006) Angiotensin II attenuates endothelium-dependent responses in the cerebral microcirculation through nox-2-derived radicals. Arterioscler Thromb Vasc Biol 26:826–832
Goldfarb RD, Marton A, Szabo E, Virag L, Salzman AL, Glock D, Akhter I, McCarthy R, Parrillo JE, Szabo C (2002) Protective effect of a novel, potent inhibitor of poly(adenosine 5′-diphosphate-ribose) synthetase in a porcine model of severe bacterial sepsis. Crit Care Med 30:974–980
Govers R, Rabelink TJ (2001) Cellular regulation of endothelial nitric oxide synthase. Am J Physiol 280:F193–F206
Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW (1994) Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141–1148
Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ Res 86:494–501
Guillot FL, Audus KL (1991) Angiotensin peptide regulation of bovine brain microvessel endothelial cell monolayer permeability. J Cardiovasc Pharmacol 18:212–218
Haddad M, Rhinn H, Bloquel C, Coqueran B, Szabo C, Plotkine M, Scherman D, Margaill I (2006) Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice. Br J Pharmacol 149:23–30
Hamon CG, Cutler P, Blair JA (1989) Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. Clin Chim Acta 181:249–254
He Z, King GL (2004) Protein kinase Cbeta isoform inhibitors: a new treatment for diabetic cardiovascular diseases. Circulation 110:7–9
Heitzer T, Krohn K, Albers S, Meinertz T (2000) Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus. Diabetologia 43:143–1438
Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, Haller H (1997) High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 81:363–371
Heumuller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP (2008) Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension 51:211–217
Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 52:846–851
Huang WC, Juang SW, Liu IM, Chi TC, Cheng JT (1999) Changes of superoxide dismutase gene expression and activity in the brain of streptozotocin-induced diabetic rats. Neurosci Lett 275:25–28
Ihlemann N, Rask-Madsen C, Perner A, Dominguez H, Hermann T, Kober L, Torp-Pedersen C (2003) Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 285:H875–H882
Inoguchi T, Sonta T, Tsubouchi H, Etoh T, Kakimoto M, Sonoda N, Sato N, Sekiguchi N, Kobayashi K, Sumimoto H, Utsumi H, Nawata H (2003) Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase. J Am Soc Nephrol 14:S227–S232
Kamata K, Kobayashi T (1996) Changes in superoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br J Pharmacol 119:583–589
Katakam PV, Snipes JA, Steed MM, Busija DW (2012) Insulin-induced generation of reactive oxygen species and uncoupling of nitric oxide synthase underlie the cerebrovascular insulin resistance in obese rats. J Cereb Blood Flow Metab 32:792–804
Kauppinen TM, Suh SW, Berman AE, Hamby AM, Swanson RA (2009) Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J Cereb Blood Flow Metab 29:820–829
Kazama K, Anrather J, Zhou P, Girouard H, Frys K, Milner TA, Iadecola C (2004) Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals. Circ Res 95:1019–1026
Kinoshita H, Katusic ZS (1996) Exogenous tetrahydrobiopterin causes endothelium-dependent contractions in isolated canine basilar artery. Am J Physiol 271:H738–H743
Kinoshita H, Milstien S, Wambi C, Katusic ZS (1997) Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol 273:H718–H724
Kinoshita H, Tsutsui M, Milstien S, Katusic ZS (1997) Tetrahydrobiopterin, nitric oxide and regulation of cerebral arterial tone. Prog Neurobiol 52:295–302
Kobayashi T, Kamata K (1999) Relationship among cholesterol, superoxide anion and endothelium-dependent relaxation in diabetic rats. Eur J Pharmacol 367:213–222
Kohli R, Meininger CJ, Haynes TE, Yan W, Self JT, Wu G (2004) Dietary l-arginine supplementation enhances endothelial nitric oxide synthesis in streptozotocin-induced diabetic rats. J Nutr 134:600–608
Kokoglu E, Belce A, Gumustas K, Altug T (1994) A possible relationship between superoxide dismutase and chronic complications of diabetes mellitus in the brain. Med Sci Res 22:781–782
Kontos HA, Wei EP, Ellis EF, Jenkins LW, Povlishock JT, Rowe GT, Hess ML (1985) Appearance of superoxide anion radical in cerebral extracellular space during increased prostaglandin synthesis in cats. Circ Res 57:142–151
Kontos HA, Wei EP, Kukreja RC, Ellis EF, Hess ML (1990) Differences in endothelium-dependent cerebral dilation by bradykinin and acetylcholine. Am J Physiol 258:H1261–H1266
Kontos HA, Wei EP, Povlishock JT, Christman CW (1984) Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ Res 55:295–303
Kontos HA, Wei EP, Povlishock JT, Kukreja RC, Hess ML (1989) Inhibition by arachidonate of cerebral arteriolar dilation from acetylcholine. Am J Physiol 256:H665–H671
Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW (2002) Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol 283:H406–H411
Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, Harrison DG (2002) Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40:511–515
Le Page C, Sanceau J, Drapier JC, Wietzerbin J (1998) Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun 243:451–457
Lee TS, Saltsman KA, Ohashi H, King GL (1989) Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci 86:5141–5145
Lenzser G, Kis B, Snipes JA, Gaspar T, Sandor P, Komjati K, Szabo C, Busija DW (2007) Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J Cereb Blood Flow Metab 27:1318–1326
Lieberman J, Sastre A (1980) Serum angiotensin-converting enzyme: elevations in diabetes mellitus. Ann Intern Med 93:825–826
Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD (2003) Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93:573–580
Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347
Loot AE, Schreiber JG, Fisslthaler B, Fleming I (2009) Angiotensin II impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase. J Exp Med 206:2889–2896
Magnuson DK, Maier RV, Pohlman TH (1989) Protein kinase C: a potential pathway of endothelial cell activation by endotoxin, tumor necrosis factor, and interleukin-1. Surgery 106:216–223
Manabe K, Shirahase H, Usui H, Kurahashi K, Fujiwara M (1989) Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J Pharmacol Exp Ther 251:317–320
Martin S (1997) Soluble adhesion molecules in type 1 diabetes mellitus. Horm Metab Res 29:639–642
Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A (2000) Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 106:1521–1530
Mayhan WG, Arrick DM, Sharpe GM, Patel KP, Sun H (2006) Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus. Microcirculation 13:567–575
Mayhan WG, Patel KP (1995) Acute effects of glucose on reactivity of the cerebral microcirculation: role of activation of protein kinase C. Am J Physiol 269:H1297–H1302
Mayhan WG, Sharpe GM (2001) Generation of superoxide anion impairs histamine-induced increases in macromolecular efflux. Microvasc Res 61:275–281
Mayhan WG, Simmons LK, Sharpe GM (1991) Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 260:H319–H326
McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD (2005) Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 25:502–512
Minchenko AG, Stevens MJ, White L, Abatan OI, Komjati K, Pacher P, Szabo C, Obrosova IG (2003) Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation. FASEB J 17:1514–1516
Modrick ML, Didion SP, Lynch CM, Dayal S, Lentz SR, Faraci FM (2009) Role of hydrogen peroxide and the impact of glutathione peroxidase-1 in regulation of cerebral vascular tone. J Cereb Blood Flow Metab 29:1130–1137
Modrick ML, Didion SP, Sigmund CD, Faraci FM (2009) Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 296:H1914–H1919
Munzel T, Gori T, Bruno RM, Taddei S (2010) Is oxidative stress a therapeutic target in cardiovascular disease? Eur Heart J 31:2741–2748
Nangle MR, Cotter MA, Cameron NE (2003) Protein kinase Cbeta inhibition and aorta and corpus cavernosum function in streptozotocin-diabetic mice. Eur J Pharmacol 475:99–106
Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787–790
O’Driscoll G, Green D, Rankin J, Stanton K, Taylor R (1997) Improvement in endothelial function by angiotensin converting enzyme inhibition to insulin-dependent diabetes mellitus. J Clin Invest 100:678–684
Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, Nagase R, Wada J, Shikata Y, Makino H (2003) Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes 52:2586–2593
Ozkaya YG, Agar A, Yargicoglu P, Hacioglu G, Bilmen-Sarikcioglu S, Ozen I, Aliciguzel Y (2002) The effect of exercise on brain antioxidant status of diabetic rats. Diabetes Metab 28:377–384
Pacher P, Liaudet L, Garcia Soriano F, Mabley JG, Szabo E, Szabo C (2002) The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 51:514–521
Pannirselvam M, Simon V, Verma S, Anderson T, Triggle CR (2003) Chronic oral supplementation with sepiapterin prevents endothelial dysfunction and oxidative stress in small mesenteric arteries from diabetic (db/db) mice. Br J Pharmacol 140:701–706
Pannirselvam M, Verma S, Anderson TJ, Triggle CR (2002) Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db –/–) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 136:255–263
Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL (2000) Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49:1239–1248
Pelligrino DA, Koenig HM, Wang Q, Albrecht RF (1994) Protein kinase C suppresses receptor-mediated pial arteriolar relaxation in the diabetic rat. Neuroreport 5:417–420
Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C (2006) Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99:69–77
Pieper AA, Brat DJ, Krug DK, Watkins CC, Gupta A, Blackshaw S, Verma A, Wang ZQ, Snyder SH (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc Natl Acad Sci USA 96:3059–3064
Pieper AA, Verma A, Zhang J, Snyder SH (1999) Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171–181
Pieper GM, Gross GJ (1988) Oxygen free radicals abolish endothelium dependent relaxation in diabetic rat aorta. Am J Physiol 255:H825–H833
Pieper GM, Haq RU (1997) Activation of nuclear factor-κB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. J Cardiovasc Pharmacol 30:528–532
Pieper GM, Langenstroer P, Siebeneich W (1997) Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 34:145–156
Pollock DM (2005) Endothelin, angiotensin, and oxidative stress in hypertension. Hypertension 45:477–480
Potenza MA, Gagliardi S, Nacci C, Carratu’ MR, Montagnani M (2009) Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem 16:94–112
Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG (1996) Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations in vascular tone. J Clin Invest 97:1916–1923
Reeves EP, Dekker LV, Forbes LV, Wientjes FB, Grogan A, Pappin DJ, Segal AW (1999) Direct interaction between p47phox and protein kinase C: evidence for targeting of protein kinase C by p47phox in neutrophils. Biochem J 344:859–866
Ribau JCO, Hadcock SJ, Teoh K, DeReske M, Richardson M (1999) Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. J Surg Res 85:225–233
Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167–178
Rosenblum WI (1997) Tetrahydrobiopterin, a cofactor for nitric oxide synthase, produces endothelium-dependent dilation of mouse pial arterioles. Stroke 28:186–189
Ryan MJ, Didion SP, Mathur S, Faraci FM, Sigmund CD (2004) Angiotensin II-induced vascular dysfunction is mediated by the AT1A receptor in mice. Hypertension 43:1074–1079
Schernthaner G, Schwarzer C, Kuzmits R, Muller MM, Klemen U, Freyler H (1984) Increased angiotensin-converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetes vascular disease. J Clin Pathol 37:307–312
Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT (2004) Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369–30374
Sharma A, Bernatchez PN, de Haan JB (2012) Targeting endothelial dysfunction in vascular complications associated with diabetes. Int J Vasc Med 2012:750126
Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588
Siflinger-Birnboim A, Johnson A (2003) Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol 284:L435–L451
Stralin P, Karlsson K, Johansson BO, Marklund SL (1995) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15:2032–2036
Suh SW, Aoyama K, Chen Y, Garnier P, Matsumori Y, Gum E, Liu J, Swanson RA (2003) Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 23:10681–10690
Sun H, Mayhan WG (2005) Sex difference in nitric oxide synthase-dependent dilatation of cerebral arterioles during long-term alcohol consumption. Alcohol Clin Exp Res 29:430–436
Sun H, Patel KP, Mayhan WG (2001) Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol consumption. Am J Physiol Heart Circ Physiol 281:H1863–H1869
Szabo C (2005) Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. Pharmacol Res 52:34–43
Szabo C (2005) Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res 52:60–71
Szabo C (2009) Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 156:713–727
Szabo C, Pacher P, Zsengeller Z, Vaslin A, Komjati K, Benko R, Chen M, Mabley JG, Kollai M (2004) Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose) polymerase activation. Mol Med 10:28–35
Szabo C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287–298
Tachi Y, Okuda Y, Bannai C, Bannai S, Shinohara M, Shimpuku H, Yamashita K, Ohura K (2001) Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue. Life Sci 69:1039–1047
Tang XN, Cairns B, Cairns N, Yenari MA (2008) Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 154:556–562
Tesfamariam B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16:383–391
Tesfamariam B, Jakubowski JA, Cohen RA (1989) Contraction of diabetic rabbit aorta caused by endothelium-derived p GH2–TxA2. Am J Physiol 257:H1327–H1333
Thomas SR, Witting PK, Drummond GR (2008) Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10:1713–1765
Tian J, Wen Y, Yan L, Cheng H, Yang H, Wang J, Kozman H, Villarreal D, Liu K (2011) Vascular endothelial dysfunction in patients with newly diagnosed type 2 diabetes and effects of 2-year and 5-year multifactorial intervention. Echocardiography 28:1133–1140
Tilton RG (2002) Diabetic vascular dysfunction: links to glucose-induced reductive stress and VEGF. Microsc Res Tech 57:390–407
Timimi FK, Ting HH, Haley EA, Roddy MA, Ganz P, Creager MA (1998) Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J Am Coll Cardiol 31:552–557
Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97:22–28
Touyz RM (2008) Apocynin, NADPH oxidase, and vascular cells: a complex matter. Hypertension 51:172–174
Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, Schiffrin EL (2002) Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90:1205–1213
Trauernicht AK, Sun H, Patel KP, Mayhan WG (2003) Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats. Stroke 34:2698–2703
Tsutsui H, Kinugawa S, Matsushima S (2011) Oxidative stress and heart failure. Am J Physiol Heart Circ Physiol 301:H2181–H2190
Ueno Y, Kizaki M, Nakagiri R, Kamiya T, Sumi H, Osawa T (2002) Dietary glutathione protects rats from diabetic nephropathy and neuropathy. J Nutr 132:897–900
Vancurova I, Miskolci V, Davidson D (2001) NF-kappa B activation in tumor necrosis factor alpha-stimulated neutrophils is mediated by protein kinase Cdelta. Correlation to nuclear Ikappa Balpha. J Biol Chem 276:19746–19752
Vanhoutte PM (2001) Endothelium-derived free radicals: for worse and for better. J Clin Invest 107:23–25
Vasquiz-Vivar J, Martasek P, Whitsett J, Joseph J, Kalyanaraman B (2002) The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J 362:733–739
Venugopal SK, Devaraj S, Yang T, Jialal I (2002) Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha. Diabetes 51:3049–3054
Vetri F, Chavez R, Xu HL, Paisansathan C, Pelligrino DA (2013) Complex modulation of the expression of PKC isoforms in the rat brain during chronic type 1 diabetes mellitus. Brain Res 1490:202–209
Vetri F, Xu H, Paisansathan C, Pelligrino DA (2012) Impairment of neurovascular coupling in type 1 diabetes mellitus in rats is linked to PKC modulation of BK(Ca) and Kir channels. Am J Physiol Heart Circ Physiol 302:H1274–H1284
Virdis A, Ghiadoni L, Taddei S (2010) Human endothelial dysfunction: EDCFs. Pflugers Arch 459:1015–1023
Wei EP, Ellison MD, Kontos HA, Povlishock JT (1986) O2 radicals in arachidonate induced increased blood-brain barrier permeability to proteins. Am J Physiol 251:H693–H699
Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT (1985) Superoxide generation and reversal of acetylcholine induced cerebral arteriolar dilation after acute hypertension. Circ Res 57:781–787
Wolf G (2004) New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 34:785–796
Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J (1991) Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87:31–38
Wong WT, Tian XY, Xu A, Ng CF, Lee HK, Chen ZY, Au CL, Yao X, Huang Y (2010) Angiotensin II type 1 receptor-dependent oxidative stress mediates endothelial dysfunction in type 2 diabetic mice. Antioxid Redox Signal 13:757–768
Yakubu MA, Sofola OA, Igbo I, Oyekan AO (2004) Link between free radicals and protein kinase C in glucose-induced alteration of vascular dilation. Life Sci 75:2921–2932
Yoshida K, Yasujima M, Kohzuki M, Kanazawa M, Yoshinaga K, Abe K (1992) Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension 20:292–297
Zhang L, Zalewski A, Liu Y, Mazurek T, Cowan S, Martin JL, Hofmann SM, Vlassara H, Shi Y (2003) Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 108:472–478
Zingarelli B, Salzman AL, Szabo C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85–94
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Arrick, D.M., Mayhan, W.G. (2014). Cerebrovascular Disease in Type 1 Diabetes: Role of Oxidative Stress. In: Obrosova, I., Stevens, M., Yorek, M. (eds) Studies in Diabetes. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4899-8035-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-8035-9_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4899-8034-2
Online ISBN: 978-1-4899-8035-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)